Expression profiling analysis in human lung tumors has confirmed the importance of the ErbB2/Akt/ELF3 signaling pathway as a prognostic biomarker and therapeutic drug target for lung cancer treatment [53]. This evidence concerns the gene AKT1 and lung carcinoma.